CRP and metabolic dysfunction-associated steatotic liver disease: Therefore, in asymptomatic subjects with NAFLD, especially those with high hs-CRP, prevention of subclinical atherosclerosis through lifestyle modification and further reversal of fatty liver and systemic inflammation is critical.